Advances In Cell And Gene Therapy Analytics - How To Use Maurice To Characterize AAVs And LNPs
Source: bio-techne
Learn how Maurice can be used to measure surface charge of an LNP-based mRNA vaccine for confirmation of LNP identity in a manufacturing setting, and for stability assessment for process and formulation development. You will also learn how to assess purity, stability and concentration of AAVs.
Speakers:
- John Loughney, Director, Vaccine Analytical Research & Development, Merck & Co., Inc.
- Chris Heger, Director, Applications Science, Analytical Solutions, Bio-Techne
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
bio-techne
This website uses cookies to ensure you get the best experience on our website. Learn more